Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MIRM
#1177
Mirum Pharmaceuticals, Inc. - common stock
99.7
5
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.26%
Monthly Change
-10.97%
6 month change
+9.78%
Year Change
+42.24%
Previous Close
98.5
1
Open
99.7
5
Low
99.7
5
High
99.7
5
Volume
70
Markets
US Stock Market
Healthcare
Biotechnology
MIRM
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
30.42 M
31.73 M
37.95 M
47 M
49.01 M
60.34 M
64.93 M
Valuation ratios
Enterprise value
389.04 M
474.76 M
703.69 M
1.43 B
2.11 B
4.78 B
6.84 B
Price to earnings ratio
—
—
-4.8
-7.5
-22.35
-168.06
-6.8
Price to sales ratio
—
—
8.5
6.59
5.83
7.61
9.16
Price to cash flow ratio
—
—
-5.45
17.3
190.32
71.03
-26.24
Price to book ratio
—
—
4.61
4.94
8.71
12.6
6.44
Enterprise value to EBITDA ratio
—
-2.75
-5.5
-14.56
-33.02
2 267.31
-8.47
Profitability ratios
Return on assets %
-0.43
-0.29
-0.38
-0.25
-0.13
-0.03
-0.06
Return on equity %
-0.6
-0.7
-0.96
-0.66
-0.39
-0.07
6.45
Return on invested capital %
-2 442.39
-1 010.86
-339.27
-197.68
-125.01
-32.94
-35
Gross margin %
—
100
100
100
100
100
100
Operating margin %
—
-906.12
-170.28
-58.57
-26
-4.25
-24.14
EBITDA margin %
—
-903.01
-166.08
-52.76
-18.99
0.4
-20.2
Net margin %
—
-438.85
-176.05
-87.68
-26.1
-4.48
-38.14
Liquidity ratios
Quick ratio
—
3.88
2.85
4.19
2.93
2.55
2.74
Current ratio
12.8
3.91
2.94
4.45
3.1
2.67
2.86
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
0.07
0.24
0.37
0.51
0.62
0.18
Solvency ratios
Debt to assets ratio
—
—
—
0.47
0.46
0.37
0.72
Debt to equity ratio
—
—
—
1.23
1.37
0.98
-71.97
Long term debt to total assets ratio
—
—
—
0.47
0.46
0.37
0.72
Long term debt to total equity ratio
—
—
—
1.23
1.37
0.98
-71.97
Per share metrics
Operating cash flow per share
—
—
-3.54
-1.74
0.22
1.11
-3.77
EBIT per share
—
—
-3.86
-2.67
-1.84
-0.44
-14.13
EBITDA per share
—
—
-3.77
-2.4
-1.35
0.04
-13.68
Total debt per share
—
—
—
7.49
6.48
6.17
11.84
Cash per share
—
—
4.46
7
5.9
7.64
6.92
Net current asset value per share
—
—
5.6
9.48
8.27
10.95
10.04
Tangible book value per share
—
—
4.18
6.08
4.75
1.07
-4.07
Working capital per share
—
—
3.69
7.35
5.6
6.85
6.53
Book value per share
—
—
4.18
6.08
4.75
6.27
-0.16
News
Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised
Insmed Catapults 30%, Leading A Biotech Rally. But Mirum Takes A Bath.
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2026 Earnings Call Transcript
Compared to Estimates, Mirum Pharmaceuticals (MIRM) Q2 Earnings: A Look at Key Metrics
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Beats Revenue Estimates
Profitable Biotechs Strut Their Stuff As Stock Market Stumbles
Vir Biotechnology: Multiple Catalysts In Hepatitis And Oncology Ahead (NASDAQ:VIR)
Valero, Marathon, Other Oil Firms Defy Weak Market, Hit Record Highs, Lead 21 Onto Best Stock Lists
Stocks To Watch: 14 Names Test And Tease New Buy Zones
SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)
Mirum Pharmaceuticals: This Liver Disease Juggernaut Broadened Its Portfolio (NASDAQ:MIRM)
Morgan Stanley, Dell, Other Rising Leaders Join IBD Top Stock Screens